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Here, we present the first report of one suspected dead case and two confirmed rapid-
onset fatal infections caused by a newly emerging hypervirulent Klebsiella pneumoniae
ST86 strain of serotype K2. The three cases occurred in a surgery ward during 2013
in Shanghai, China. A combination of multilocus sequence typing, pulsed-field gel
electrophoresis, phenotypic and PCR tests for detecting virulence factors (VFs) was
used to identify the isolates as K2 ST86 strains with common VFs, including Aerobactin
and rmpA. Furthermore, the two K2 ST86 strains additionally harbored a distinct VF kfu
(responsible for iron uptake system), which commonly existed in invasive K1 strains
only. Thus, the unusual presence of both K1 and K2 VFs in the lethal ST86 strain
might further enhance its hypervirulence and cause rapid onset of a life-threatening
infection. Nevertheless, despite the administration of a combined antibiotic treatment,
these three patients all died within 24 h of acute onset, thereby highlighting that the
importance of early diagnosis to determine whether the ST86 strains harbor key K2
VF and unusual K1 kfu and whether patients should receive a timely and targeted
antibiotic therapy to prevent ST86 induced fatal pneumonia. Finally, even though
these patients are clinically improved, keeping on with oral antibiotic treatment for
additional 2–3 weeks will be also vital for successfully preventing hvKP reinfection or
relapse.
Keywords: hypervirulent Klebsiella pneumoniae (hvKP), pyogenic liver abscess (PLA), ST86, virulence factors
(VFs), iron-uptake system (kfu)
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Introduction
Here, we report that one suspected dead case and two conﬁrmed,
rapid onset and fatal infections caused by aKlebsiella pneumoniae
ST86 strain occurred in a three-bed surgery ward of a university
hospital with 1,800 beds and 40,000 annual admissions in
Shanghai, China in 2013 (See Figure 1).
The ﬁrst suspected patient, a 64-year-old male, after
resuscitation from acute recurrent myocardial infarction, was
sent to the surgery ward at 3 PM, on May 31th. In addition, the
patient has the following diseases: coronary atherosclerotic heart
disease, cerebral infarction, hypertension, type 2 diabete, and
hyperlipoidemia. Since June 1st, the patient was initially treated
empirically with moxiﬂoxacin (400 mg daily) and gradually
improved. At that time, the WBC count was 9.10 × 109/L with
64.3% granulocytes and 20.7% lymphocytes. However, on June
4th, his WBC count increased to 9.59 × 109/L with unusual
82.0% granulocytes and 8.1% lymphocytes, accompanied by a
high temperature, breathing diﬃculty, and brick red foamy
blood sputum, and followed by respiratory distress syndrome.
Immediately, the patient was transferred into an intensive care
unit (ICU) and died at 4 AM, on June 5th. Since samples were
not collected as a result of the patient’s sudden death, this case
was listed as a suspected case and potential source of infection
only.
The second patient, a 72-year-old male, was admitted due
to chordae tendineae of mitral valve and mitral incompetence
on May 16th. At the beginning of admission, the patient
showed clear breathing sounds, but no cough, expectoration,
and wheezing sound. On May 29th, the patient recovered
well in the ICU and was transferred to the same surgery
ward. Until August 4th, the chest wound of the patient still
didn’t heal well and followed by the exudates containing plenty
of thick, tan-black colored secretion. The WBC count was
12.91 × 109/L with 85.9% granulocytes and 7.9% lymphocytes.
However, microbiological culture of tan-black colored secretion
was negative. At 1 AMon June 8th, the patient’s body temperature
suddenly increased to 39.2◦C, accompanied by chest tightness,
shortness of breath, coarse breath sounds, brick red foamy
blood sputum, expectoration and wheezing as well as coarse
rales. At that time, the WBC count decreased to 8.48 × 109/L
with 91.0% granulocytes and 4.7% lymphocytes. Subsequently,
the patient was transferred into the ICU and immediately
treated with linezolid and cefoperazone/sulbactam. However,
his condition deteriorated late at night on June 8th and he
eventually died from multiple organ failure caused by severe
pneumonia and septic shock at 1:30 AM, June 9th. A routine
microbiological culture of blood sample remained negative.
However, a K. pneumoniae strain Kp523 from a sputum sample
was isolated.
The third patient, a 74-year-old male, having a long
disease history of ischemic cardiomyopathy and old myocardial
infarction, was the ﬁrst one admitted to the ward on April 18th,
because of the unsuccessful percutaneous coronary intervention,
and daily treated with moxiﬂoxacin (400 mg daily). However,
on the night of May 25th, some unexpected symptoms,
including chest tightness and shortness of breath, suddenly
appeared for large eﬀusions in right pleural and resulted in
a restrictive ventilatory dysfunction. And the WBC count was
15.8 × 109/L with 93.8% granulocytes and 3.8% lymphocytes.
After discharging more than 1,100 ml dark-red colored eﬀusions
in right pleural, the patient condition obviously improved.
And microbiological culture of the pleural eﬀusion sample
was still negative. Until June 3rd, the patient had almost
completely recovered with most parameters of routine blood
tests being near normal (6.3 × 109/L WBC with 71.3%
granulocytes and 16.0% lymphocytes). Thus antibiotic treatment
was stopped. Unexpectedly, at 10:40 PM, on June 8th, the patient
experienced acute pneumonia including high temperature
(39.0◦C), red foamy bloody sputum, breathing diﬃculty and
low oxygen saturation, immediately followed by respiratory
distress syndrome. The patient was rapidly transferred to the
ICU. At 9 PM on June 9th, despite combination therapy of
ganciclovir, imipenem/cilastatin, tigecycline, and hemoﬁltration,
the patient deteriorated and ﬁnally died of multiple organ
failure caused by severe pneumonia and septic shock at 11:45
PM, June 10th. Subsequent routine microbiological culture of
blood sample successfully isolated K. pneumoniae strain named
Kp562.
The protocol for this study was approved by Ethics Committee
of Ruijin Hospital, Shanghai JiaoTong University School of
Medicine. The combination of routine PFGE and MLST typing
revealed that the two isolates shared highly similar PFGE proﬁles
as K. pneumoniae ST86 (Figure 2A). Via PCR targeting wzx
gene of capsule serovar K1, K2,(Yu et al., 2008) and aerobactin,
allS, kfu, magA, and rmpA (Lin et al., 2014). The detailed PCR
conditions listed in Supplementary Table S1. The two strains
were conﬁrmed as serotype K2 and Aerobactin-kfu-rmpA
positive but magA-allS negative (Figure 2B). The two isolates
grew as positive hypermucoviscous phenotype (HV) with a
mucoviscous string > 5 mm in length from the colony on the
blood agar plate (Figure 2C). Moreover, except nitrofurantoin
and ampicillin, the two isolates exhibited susceptibility to the
other 16 antimicrobial agents including ampicillin/sulbactam,
piperacillin/tazobactam, cefazolin, cefotetan, ceftazidime,
ceftriaxone, cefepime, aztreonam, ertapenem, imipenem,
amikacin, gentamicin, tobramycin, ciproﬂoxacin, levoﬂoxacin,
and trimethoprim/sulfamethoxazole using Vitek 2 automated
system (BioMérieux, St Louis, MO, USA) according the Clinical
and Laboratory Studies Institute guidelines (CLSI2013).
Background
During the previous decades, infections due to K. pneumoniae
have primarily been attributed to classic K. pneumoniae (cKP)
strains. However, since the ﬁrst hypervirulent K. pneumoniae
(hvKP) strain causing distinct pyogenic liver abscess (PLA)
were reported in Taiwan in 1986, the new phenotypic hvKP
strains have been increasingly common worldwide (Shon et al.,
2013). Compared to the cKP strains, the unique clinical features
of the hvKP strains are their ability to cause life-threatening
community-acquired invasive infections (Shon et al., 2013).
The invasive nature of the hvKP strains has been associated
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FIGURE 1 | The clinical and epidemiological characteristics of the three cases in this study.
FIGURE 2 | (A–C) Phenotypic and molecular characteristics identification
of KP523 and KP562. (A) Genomic DNA of KP523/KP562 strains
and another clinical strain KP580 as control were digested using
XbaI enzyme and subjected to PFGE; (B) PCR genotyping
determining the presence or absence of the specific wzx gene for
capsule serovar K1, K2, Aerobactin, kfu, alls, magA, and rmpA
gene; (C) Positive hypermucoviscosity phenotype of Kp523/562 by
string test.
with multiple virulence factors (VFs), including K2-speciﬁc
regulator of mucoid phenotype A gene (rmpA), and K1-speciﬁc
mucoviscosity-associated gene A (magA), iron-uptake system
(kfu) and HTH-type transcriptional activator (allS), (Yu et al.,
2008).
In 2011, one report in France indicated that two hypervirulent
K2 ST86 strains were more virulent than those of K1 ST23 strains
(Decre et al., 2011). Actually, in 1991, the ﬁrst ST86 strain-CG43
causing severe bacteremia and PLAwas reported in Taiwan (Shon
et al., 2013). Recently, two hypervirulent K2 ST86 strains have
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been reported including strain hvKP1 isolated from a 24-year-
old Vietnamese male in New York, which caused a unique
PLA accompanied by a metastatic spread to the spleen (Russo
and Gill, 2013), while another strain, isolated in South Korea,
caused severe bacteraemic infection (Jung et al., 2013). Currently,
ST86 isolated from ﬁve PLA cases throughout Taiwan, Hong
Kong, and Singapore have been reported (Lin et al., 2014).
Here, this is the ﬁrst report of hvKP ST86 strains causing one
suspected and two conﬁrmed fatal cases in one surgery ward in
China.
Discussion
So far, compared to major ST23 of K1, not much has been
studies about ST86 strains. In the present study, we have
experimentally conﬁrmed the presence of the pivotal VFs closely
associated with PLA or hypermucoviscosity phenotype. In the
present study, the more distinct diﬀerence of the ST86 strains
than other K2 strains is the additional presence of kfu gene
exclusively in our strains. To date, most reported ST86 strains
have possessed a HV, rmpA, and PLA phenotype but no kfu.
For example, two recently published studies described that
all of the seven hvKP ST86 strains from France, USA, and
Taiwan and 11 ST86 strains from Hong Kong, Singapore,
and Taiwan, harbored no kfu gene (Suzanne et al., 2013; Lin
et al., 2014). However, the two Kp523/562 strains exhibited
HV and unique K2-Aerobactin-kfu-rmpA positive phenotypes,
yet no PLA. This may be associated with the rapid, acute
onset of disease caused by hypervirulence of ST86 strains;
the patients were dead before PLA occurred. Furthermore,
the HV-Aerobactin-rmpA positive strains of K. pneumoniae
had previously been shown to be highly lethal to mice
and were more virulent than HV-Aerobactin-rmpA negative
strains (Yu et al., 2008). It was well-known that the K1 PLA
strains carried kfu gene involved in human liver abscesses and
metastatic spread infections, though this was generally absent
in K2 strains; probably making the K1 strains signiﬁcantly
more prevalent than K2 (Yu et al., 2008). Therefore, the
acquisition of kfu gene by the Kp523/562 strains might further
enhance their hypervirulence (Ito et al., 2015). In fact, it was
recently found that certain K2 strains from other minor ST
types, like ST375 and ST380, also possessed the kfu gene,
reﬂecting that the presence of kfu gene might be closely
associated with diﬀerent genetic background or geographic
origin among serotype K2 strains (Lin et al., 2014). It is
unknown how K2 strains might obtain the kfu gene from K1
strains. Although virulence plasmid acquisition is one of major
mechanisms acquiring new gene for hvKP strains, however, as
a chromosomal virulence gene, the acquisition of kfu gene in
K2 strains might occur via horizontal gene transfer mediated
by bacteriophage or transposons. Whole genome sequencing of
the two strains and comprehensively comparing them with other
hvKP strains to further investigate the detailed mechanism of
the acquirement of kfu in K2 ST86 strain is warrant in the near
future.
Another important clinical characteristic of the hvKP ST86
strains is the high mortality rates likely due to their increased
hypervirulence. Based on these ﬁndings above, among all of
the 12 ST86-infected cases with detailed clinical information,
ST86 strains totally caused ﬁve fatal infections, seven severe
PLA, and one bacteraemic infection. It seems that mortality
rate (41.6%, 5/12) caused by ST86 was obviously higher
than that of other hypermucoviscositic strains, such as 7.3%
in Canada, (Peirano et al., 2013), 3.0 and 31% in Taiwan
(Ko et al., 2002; Ku et al., 2008). The signiﬁcant mortality
rate might be primary due to availability of very limited
data reporting the prevalence and characteristics of ST86
worldwide.
On the other hand, despite the high prevalence of ST86
accounting for 46% PLA cases in other Asia countries/regions
(Lin et al., 2014), there have only been two recent reports which
concluded that only two out of 84 PLA-causing strains were
ST86 strains in China. This suggests that both severe onset and
rapid death were caused by its hypervirulence without PLA and
that the prevalence of ST86 infection in China could be greatly
underestimated (Li et al., 2014; Liu et al., 2014).
Concluding Remarks
In this study, for the ﬁrst time, unusual VF proﬁles correlating
with the hypervirulence of ST86 strain causing two rapid-onset
fatal infections were identiﬁed. However, regarding very little
data of ST86 presently available, thus further molecular and
epidemiological characterization studies should be performed to
reveal the distribution and clinical importance of the unusual
virulence factor proﬁles of hvKP ST86 strains originating from
diﬀerent geographic regions or countries outside Asia. Based on
our ﬁnding, despite antibiotic therapy after acute onset, all of the
two conﬁrmed and one suspected patients rapidly deteriorated
and eventually died. Therefore, combined application of MLST
and VF detection implemented immediately to conﬁrm the
presence of hvKP ST86 strains should be crucially important for
the doctor to early treat the patients with antibiotics if they carry
the ST86 strains with Aerobactin-kfu-rmpA phenotype, even they
don’t have any clinical signs of this disease at that time. Moreover,
when these patients have been clinically improved, keeping on
with oral antibiotic treatment for additional 2–3 weeks will be
also vital for successfully preventing reinfection or relapse of
hvKP strains.
Supplementary Material
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2015.00721
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